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Abbreviations: 
 
CIT: cold ischaemia time 
DD: deceased donor 
DCD: donation after circulatory death 
DBD: donation after brain death 
DGF: delayed graft function 
H&I: Histocompatibility and Immunogenetics 
NHSBT: National Health Service Blood and Transplant 
XM: crossmatch 
pXM: prospective crossmatch 
vXM: virtual crossmatch 
SN-OD: Specialist nurses in organ donation 
DO: duty office 
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Abstract: 
Background: Prolonged cold ischaemia time (CIT) is associated with a significant 
risk of short and long-term graft failure in deceased donor (DD) kidney 
transplants across the world. The aim of this prospective longitudinal study was 
to determine the importance of logistical factors on CIT. 
Method: Data on 1763 transplants were collected prospectively over 14 months 
from personnel in 16 transplant centres, 19 Histocompatibility and 
Immunogenetics laboratories, transport providers and NHS Blood and 
Transplant (NHSBT).  
Results: The overall mean CIT was 13.8 hours, with significant centre variation 
(p<0.0001). Factors that significantly reduced CIT were donation following 
circulatory death (DCD)(p=0.03), shorter transport time (p=0.0002), use of 
virtual crossmatch p<0.0001) and use of donor blood for pre-transplant 
crossmatch  (p<0.0001). CIT for transplants that went ahead with a virtual 
crossmatch was 3 hours shorter than those requiring a pre-transplant 
crossmatch (p<0.0001). There was a mean delay of 3 hours in starting 
transplants despite organ, recipient and pre-transplant XM result being ready, 
suggesting that theatre access contributes significantly to increased CIT.  
Discussion: This study identifies logistical factors relating to donor, transport, 
crossmatching, recipient and theatre that impact significantly on CIT in DD renal 
transplantation, some of which are modifiable; attention should be focussed on 
addressing all of these.  
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Introduction 
Delayed graft function (DGF), which can be defined as the requirement for 
dialysis in the first 7 days post-transplant, occurs in a significant number of 
deceased donor renal transplants, cited as between 25 and 50% 1, and is 
associated with a significantly increased risk of graft loss over the years 
following transplantation, higher serum creatinine at one year, and an increased 
risk of acute rejection 2.  Risk factors for DGF include cold ischaemia time (CIT), 
donor factors such as age and serum creatinine, recipient factors such as body 
mass index, immunological and logistical factors 3. Of these, prolonged CIT has 
been shown to be the most significant individual factor in predicting delayed 
graft function: Irish et al reported that for every hour increased CIT there was a 
4% increased risk of DGF 4. Cold ischaemia time is defined as the time from 
commencement of cold perfusion at the time of donor surgery to the removal of 
the kidney from ice in the recipient centre, and is affected by a complex logistical 
pathway that includes kidney allocation, transport, crossmatching, preparation 
of the recipient and access to theatre. 
  
Kidneys that are particularly susceptible to ischaemic damage and DGF are those 
from deceased donors following circulatory death (DCD), and extended criteria 
donors (older (>60 years) donors and those with co-morbidities, eg 
cardiovascular disease) 5. With increasing numbers of patients waiting for 
transplantation, more such organs are accepted and thus CIT will remain an 
important consideration in deceased donor transplantation 6,7. We prospectively 
studied the impact of individual logistical factors on CIT, relating to events from 
the time of kidney retrieval at the donor hospital to kidney being removed from 
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 6 
ice in the recipient centre (Figure 1). Whilst logistical details vary between 
nations and organ sharing schemes, our findings are worthy of careful reflection 
internationally. 
 
Results 
General Demographics 
Data include information for 1763 single/double/en-bloc kidney only and SPK 
transplants from across the United Kingdom. Of those, 1586 (90%) were kidney 
only and 177 (10%) SPK transplants. Fifty-five of the 1586 kidney only 
transplants were double and 4 were en-bloc kidney transplants. DCD kidneys 
constituted more than a third (41%) of the transplants and the majority of 
kidneys (64%) were shipped between centres. 43 (2%) kidneys were 
reallocated: 32 were reallocated locally and 11 were reallocated to a different 
transplant centre.  
 
Cold ischaemia times  
The overall mean CIT for kidney transplants in all transplant centres was 13.8 
hours (SD 4.5, IQR 10.7-16.4). The shortest recorded CIT was 3.7 hours and the 
longest was 33.1 hours. 
 
There was significant centre variation in mean CIT across the UK transplant 
centres ranging between the shortest of 12.0 hours and the longest of 20.4 hours 
in the 22 centres (F=10.060, p<0.0001), as shown in Figure 2.  
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The most significant factor affecting CIT overall was the adoption of a virtual 
crossmatch policy. Transplants that required a prospective pre-transplant 
crossmatch had a CIT that was 3 hours longer than those where the crossmatch 
test was omitted and proceeded directly to transplant based on a negative virtual 
crossmatch (Figure 3, p<0.0001). There was significant centre variation in the 
number of transplants performed using vXM; indeed at the time of the study two 
centres had not adopted a virtual crossmatch policy (P<0.0001). Due to the key 
role played by the type of crossmatch performed and the fact that the kidney 
pathway diverges depending on whether the transplant requires a pre-
transplant cross match or not, the analysis was performed separately for virtual 
crossmatch (vXM) and pre-transplant crossmatch (pXM) groups. 
 
If a pre-transplant crossmatch is required this can be performed using donor 
peripheral blood obtained pre-retrieval, or lymph node and spleen that are taken 
at time of retrieval and accompany the organs to the recipient centre. We sought 
to determine whether there was variation in practice with regard to use of donor 
tissue for pXM, as this was likely to significantly alter the timing of availability of 
the XM result. There were significant differences in laboratory practice, with one 
laboratory performing approximately 89% pXM on peripheral blood, whilst 
other laboratories were dependent on the arrival of lymph nodes and spleen in 
all cases (Figure 4). 
 
The factors that were included in a univariate analysis for both vXM and pXM 
groups are outlined in Table 1 (categorical) and Table 2 (continuous). These 
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 8 
include factors pertaining to each stage of the kidney journey from donor to 
recipient, and key timelines of the process.  
 
Factors affecting CIT in transplants requiring pre-transplant crossmatch 
test (univariate analysis) 
In the pre-transplant crossmatch group, several factors contributed significantly 
to CIT in univariate analysis: CIT was significantly shorter in DCD transplants 
than DBD (p=0.0003); kidneys that were transplanted locally had a shorter CIT 
than those that were exported (p<0.0001), and CIT was prolonged if kidneys 
were reallocated either locally or to a second centre (p=0.0007). Importantly, if 
the prospective crossmatch was performed using donor peripheral blood 
obtained prior to start of retrieval, rather than donor lymph nodes and spleen 
obtained at retrieval and transported with the organs, CIT was significantly 
reduced (p<0.0001). Similarly, if stored recipient blood was available for 
crossmatching purposes, this resulted in a significant reduction in CIT 
(p<0.0001). Continuous variables that were found to contribute to CIT in the 
prospective crossmatch group were transport times, time taken from in situ cold 
perfusion to the kidney boxed ready for transport, time between the offer made 
and the kidney accepted by the recipient centre, and time to obtain the 
crossmatch result. Once the kidney had arrived and pXM result known, any 
further delay in proceeding with the transplant was documented, and was found 
to have a significant impact on CIT. 
 
Factors affecting CIT in transplants undertaken using virtual crossmatch 
(univariate analysis) 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 9 
Significant factors in univariate analysis were donor type (DBD/DCD) (p=0.01), 
and whether the kidney was allocated locally or imported from another region 
(p=0.04). In the small number of kidneys that were reallocated, this had a 
significantly detrimental impact on CIT (p<0.0001). Requirement for recipient 
haemodialysis pre-transplant also had a significant impact (p=0.003). 
Continuous factors that were relevant included timing from cold perfusion to 
kidney boxed ready for transport, offer accepted to contacting the recipient, 
timing of kidney collection and its transport. 
 
Multivariate analysis of factors affecting CIT  
All factors that were significant in univariate analyses were considered in 
multivariate modelling, and factors that remained significant are shown in Table 
3. Key findings in the prospective crossmatch group are shown in Table 3a: if 
peripheral blood is used for pXM, CIT is reduced by more than 3 hours. Factors 
that led to an increased CIT are travel times (adding between 1.5 and 2.3 hours), 
or kidney reallocation (+2.6 hours). In addition, once the kidney had arrived and 
the pXM result was known, a further delay in start of surgery had a significant 
detrimental impact on CIT. This was also significant in the context of the vXM 
group (Table 3b), leading to a significant delay in commencement of surgery and 
thus increasing CIT. Other factors that remained significant in the vXM group 
were the patient requiring haemodialysis prior to transplant, travel time and 
kidney reallocation. 
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Discussion 
Cold ischaemia time is one of the few modifiable factors that have been identified 
as a significant risk factor for delayed graft function, with long term implications 
for graft survival in deceased donor renal transplants 2.8,9,10. It is likely that, in 
the current era of accepting kidneys from extended criteria donors, and DCD 
donors, CIT will continue to play a significant role, and should be minimized, as 
evidenced by the experience of the Eurotransplant Senior program11.  
 
We have examined logistical factors that contribute to CIT in the context of 
national (DBD) and regional (DCD) allocation of DCD kidneys within the United 
Kingdom. Organ retrieval, transport and implantation logistics vary between 
countries and organ sharing networks, but, studies examining these are lacking, 
despite a clear need for such investigation 12. Thus we consider the international 
relevance of factors identified in this study based on current literature available. 
One regional French study examining the impact of the introduction of a 
timesheet on CIT in locally and nationally allocated kidneys found that the 
introduction of such a time sheet alone reduced CIT from 21 hours to 13 hours in 
a case control study 13. Another review of factors affecting CIT in Chile 
highlighted the impact of kidney sharing, reallocation and factors pertaining to 
HLA typing and crossmatching 14.  
 
The factor that contributed most significantly to CIT was the introduction of a 
virtual crossmatch policy in patients that were deemed suitable for such: these 
patients have low immunological risk, with known HLA antibody profile and few 
unacceptable antigens.  This finding requires further interrogation: the 
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prolonged CIT in patients requiring a pXM may be due to other factors relating to 
their more complex sensitisation profiles. A study from Cambridge demonstrated 
that the introduction of such a policy in carefully selected patients could be 
undertaken safely and leads to an effective reduction in CIT 15,16.  
It is likely that lessons can be learned internationally from this finding. In the US, 
virtual crossmatching is adopted to predict whether or not a kidney should be 
shipped to a distant centre for transplantation into a sensitized patient, but the 
pre-transplant crossmatch is still performed on arrival of the kidney at the 
recipient centre. A review of this policy with the introduction of a virtual 
crossmatch policy is likely to lead a reduction in CIT, and might be safely 
introduced 15. However, introduction of a vXM policy does not always result in 
reduced CIT, as has been shown recently in a Swiss study: the policy led to 
improved allocation, reduced workload on the H&I staff, and improved risk 
stratification for modified immunosuppression, but CIT was the same in both 
groups17.  
 
Factors that were common to both pXM and vXM groups were travel time, 
kidney reallocation and a delay in gaining access to theatre, despite the 
availability of the crossmatch result and the kidney having arrived at the 
recipient hospital. When members of staff were interviewed at all transplanting 
centres across the UK as an early part of this work, the most commonly 
perceived reason for prolonged CIT was lack of access to theatre, due to 
competing interests of emergency cases, and availability of anaesthetic and 
theatre staff. It has been previously shown that more than 50% of kidney 
transplants are performed overnight and at weekends when there are fewer 
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operating rooms and less staff coverage (nursing, anaesthetic) 18 and we must 
implement policy changes that prioritise sufficient theatre access out of hours if 
we are to continue to strive to minimize CIT and optimise outcomes.  
 
One limitation of the study is the paucity of data relating to transport, recipient 
and surgical factors. The study relied on information being collected by 
individual members of the clinical team at the recipient hospital, resulting in 
approximately 33% data being collected. Formal collection of transport times 
has now been built into the contract of transport providers. Despite this 
shortcoming, significant and important factors have been identified, which 
remain relevant.  
 
With the introduction of novel technologies that aim to improve perfusion and 
organ preservation, such as machine perfusion and normothermic regional 
perfusion, static cold storage may become a less commonly adopted technique. 
However, whilst organs continue to be transported on ice between centres in 
order to optimize transplant outcomes, CIT remains an important factor 20. This 
study has demonstrated specific logistical factors that can be addressed with the 
potential to minimize CIT further and has international relevance as CIT is 
recognised as a key factor contributing to delayed graft function.  
 
Method: 
Data collection: 
Prospective data collection was performed between June 2011 and the end of 
July 2012. Prior to commencement of the data collection, all UK transplant 
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centres, specialist nurses for organ donation (SN-ODs) and Histocompatibility 
and Immunogenetics (H&I) laboratories were visited in order to maximize 
participation with the study. The study was funded from a research grant from 
NHS Blood and Transplant (NHSBT), and was approved by the Kidney Advisory 
Group, which advises NHSBT on all aspects of kidney transplantation within the 
UK.  Staff involved in the data collection included SN-ODs, H&I staff, transport 
providers, recipient transplant coordinators, transplant 
surgeons/fellows/specialist registrars, nephrologists, theatre and ward staff and 
NHSBT. 
 
Data were obtained on deceased donor (DD) kidney only and simultaneous 
pancreas and kidney (SPK) transplants from 16 of the 22 invited transplant 
centres (6 centres declined to participate) along with all 19 H&I laboratories 
(supporting all 22 transplant centres), with the aim of determining whether 
there are specific areas upon which to focus efforts to reduce cold ischaemia 
times. CIT was calculated from UK Transplant Registry data held by NHSBT, and 
was defined as the time from in situ cold perfusion in donor at the time of 
retrieval to the time of removal of kidney from ice for transplantation in 
recipient. This was available for all transplants performed in all 22 centres. 
 
Factors that were considered to be relevant for this study were agreed with a 
national multidisciplinary team, including transplant surgeons, H&I scientists, 
and statisticians.  In addition, draft documents were circulated to the heads of 
transplant centres for their input. Categorical and continuous data were 
collected along the kidney timeline from the time of organ donation at the donor 
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hospital to completion of transplantation at recipient hospital on four different 
data collection forms. We focused on five key logistical areas, namely, donor 
operation, organ transport, laboratory tests including the match run and the 
crossmatch, recipient preparation and theatre, as shown in Figure 1.  For clarity, 
the Duty Office (DO) at NHSBT performs the match run once the donor HLA type 
is known; this is matched to the recipient pool. We examined different factors 
within each of these key areas to identify those that impacted on CIT.  
 
A national database was set up and data input was done prospectively. Data were 
checked for errors and each outlier was examined by re-checking them against 
the original forms as well as with the rest of the data for the corresponding 
transplant. We excluded transplants that did not proceed despite retrieval of 
organs, and kidneys that were transplanted with organs other than pancreas. 
When two kidneys were transplanted in a single recipient (double kidney 
transplant) the one with the longer CIT was excluded. Data on recipient and 
theatre times that were inconsistent with the rest of the data and those that had 
a discrepancy of more than one hour from NHSBT data were excluded (n=52 
transplants). Transplants with no vXM or pXM information were excluded. Data 
cleansing was undertaken prior to the final analysis: 5% of data were selected 
randomly at regular intervals and each one was checked against the original 
forms and records to establish excellent quality assurance of the input data. An 
error rate of <1% was considered acceptable. Data were collected for almost 
100% of donor and H&I data for that period, with 37% of transport data, 32% of 
recipient and 35% of theatre data from the 16 participating centres.  
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Crossmatch terminology: 
Several centres in the UK have adopted selective omission of the pre-transplant 
crossmatch in potential recipients who are at low immunological risk 16, and this 
has shown to be safe and effective at reducing CIT 15. For the purposes of this 
study, the term ‘virtual cross match’ is used to describe this policy (vXM). 
 
For clarification in this study, we will use the term pre-transplant crossmatch for 
those transplants that required full crossmatch testing to be performed prior to 
start of surgery (pXM), and virtual crossmatch for those in whom the prospective 
pre-transplant donor crossmatch was omitted and it was safe to proceed without 
waiting for the crossmatch test to be performed (vXM). The formal crossmatch 
test was performed retrospectively and there have been no cases of unexpected 
xm positivity following transplantation.  
 
Statistical Analysis 
General demographics of deceased donor kidney and SPK transplantation in the 
14-month period included number and type of donors, kidneys, transplants, 
recipients, allocation and reallocation across the UK transplant centres.. All 
relevant time intervals were collected in hours. Various time intervals between 
donor notification and completion of transplant surgery were examined, namely, 
times of retrieval surgery, transport of organs, donor HLA typing and 
crossmatching, recipient preparation and transplant theatre. Donor-related 
categorical data included in the analyses were type of donor (DBD or DCD) and 
donor tissues used for crossmatching. Transport-related categorical data was 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 16 
mode of organ transport, H&I-related data were type of crossmatching, types of 
donor tissues and recipient blood samples used if pre-transplant crossmatch test 
done, recipient-related categorical factors included mode of recipient travel to 
the transplant centre, requirement for haemodialysis immediately prior to 
transplant and requirement for current recipient serum sample for 
crossmatching.  The sole theatre-related categorical factor included was whether 
the transplant was performed in an emergency or transplant-dedicated theatre.   
 
All data within the study period were included in the univariate analysis.  
Parametric tests were performed to assess differences in CIT across transplant 
centres and crossmatch type, variation in crossmatch across transplant centres 
and variation in practice around the use of donor samples for pre-transplant 
crossmatch.  A general linear model was used to determine the contributions of 
various factors and time intervals to the cold ischaemia time.  Due to missing 
data, time intervals were analysed categorically. The distribution of each of the 
time intervals was used to decide appropriate categories.  Factors that were 
found to be significant in the univariate analyses were incorporated in the 
multivariate modelling. Only significant factors in the multivariate modelling 
were included in the final model. 
P-values of <0.05 were considered significant. All analyses were performed using 
SPSS version 19, IBM, UK and SAS version 9.4.   
Intercept description: 
The intercept is the median cold ischaemia time if all other factors are set to zero 
(the baseline). 
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Table 1: Categorical factors included in the univariate analysis for vXM and 
pXM groups 
 
  Pre-
transplant 
crossmatch 
Virtual 
crossmatch 
TOTAL 
Factor Level N % N % N % 
Donor type DBD 703 62 333 52 1036 59 
DCD 424 38 303 48 727 41 
Local No 740 66 390 61 1130 64 
Yes 387 34 246 39 633 36 
Reallocated 
kidney 
No / 
unknown 
1104 98 616 97 1720 98 
Yes 23 2 20 3 43 2 
Peripheral 
blood 
No 867 79 -  867 79 
Yes 224 21 -  224 21 
Missing 36 -   36 - 
Current 
sample 
No  389 35 -  389 35 
Yes 709 65 -  709 65 
Missing 29 - -  29 - 
 Recipient 
mode of travel 
to hospital 
Ambulance 20 6 13 5 33 5 
Air 0 0 4 2 4 1 
Patient’s 
own 
286 81  205  77  491  79 
Taxi 46 13  44  17  90  15 
Other 1 <1  0  0  1  <1 
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Missing 774 - 370 - 1144 - 
Haemodialysis  
Required by 
recipient 
No 261 71 186 67 447  
Yes 106 29 91 33 197  
Missing 760 - 359  1119  
 
 
Definitions: 
 
Local:  when a kidney, retrieved at one of the hospitals within a defined 
geographical region, is transplanted at the designated transplant unit for that 
region 
 
Reallocation: when a kidney, which was initially accepted for transplantation in a 
particular recipient at a transplant unit, is subsequently allocated to a second 
recipient at the same or a different hospital  
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Table 2: Continuous factors included in the univariate analysis for pXM and 
vXM groups 
 Pre-transplant 
crossmatch (hrs) 
Virtual crossmatch  
(hrs) 
Factor N Median IQ Range N Median IQ 
Range 
Cold perfusion to kidney in ice 
box 
867 1.27 1.02 – 
1.55 
475 1.28 1.02 –
1.62 
Offer accepted to latest of staff 
in lab, donor sample arrive, or 
recipient sample arrive 
308 
 
9.42 6.20 – 
13.00 
-  - 
Offer accepted to agreement to 
proceed with a vXM 
- - - 197 3.00 1.13 – 
6.33 
Offer accepted to recipient 
contacted 
292 1.80 0.33 – 
6.58 
222 2.63 0.65 – 
6.25 
Recipient contacted to recipient 
arrived 
307 2.00 
 
1.33 – 
3.00 
240 2.00 1.50 – 
3.00 
Kidney on ice to kidney 
collected 
405 0.93 0.67 – 
1.25 
201 1.00 0.67 –
1.42 
Kidney collected at donor 
hospital to kidney delivered to 
recipient centre 
426 1.83 1.08 – 
3.17 
221 2.17 1.33 – 
3.42 
Matching run complete to pXM 
result 
1100 14.42 10.52 – 
19.02 
-  - 
Matching run complete to  -  - 494 4.43 1.60 – 
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agreement to proceed with a 
vXM 
9.17 
Latest (XM result known, organ 
delivered) to transplant surgery 
started 
342 3.30 2.28 – 
5.17 
82 3.82 2.53 – 
6.00 
Transplant surgery started to 
kidney out of ice 
354 0.90 0.65 – 
1.25 
264 0.87 0.70 – 
1.22 
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Table 3: Multivariate analysis of factors affecting cold ischaemic time for a) 
pre-transplant crossmatch group and b) virtual cross match group.  
Explanation of ‘intercept’ is provided in the Methods section 
Factor Level Estimated 
change in 
CIT (hours) 
Standard 
Error 
p-value 
a) Pre-transplant crossmatch 
Intercept  13.3 0.4 <0.0001 
Peripheral blood No Baseline 
 Yes -3.4 0.3 <0.0001 
Kidney collected 
to  
kidney delivered 
Less than 2hrs Baseline 
2 – 4hrs 1.5 0.5 0.0007 
More than 4hrs 2.3 0.6 0.0002 
Missing 1.3 0.3 <0.0001 
Kidney 
reallocated 
No Baseline 
 Yes 2.6 0.8 0.0019 
Cold perfusion to 
Kidney on ice 
Less than 
1hr30 
Baseline 
More than 
1hr30 
1.1 0.3 0.0004 
Missing 0.7 0.3 0.02 
Latest (XM result 
known, organ 
Less than 5hrs Baseline   
5 – 9hrs 2.1 0.5 <0.0001 
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delivered) to 
transplant 
surgery started 
More than 9hrs 5.7 1.0 <0.0001 
Missing 1.5 0.3 <0.0001 
    
b) Virtual crossmatch 
Intercept  8.7 0.7 <0.0001 
Donor type DCD Baseline 
DBD 0.8 0.4 0.03 
Recipient on HD No Baseline 
Yes 1.3 0.6 0.02 
Missing 1.3 0.4 0.002 
Kidney 
reallocated 
No Baseline 
 Yes 5.7 1.0 <0.0001 
Kidney collected 
to 
Kidney delivered 
Less than 2hrs Baseline 
2 – 4hrs 1.6 0.6 0.01 
More than 4hrs 2.8 0.9 0.002 
Missing 1.8 0.5 0.0004 
Latest (proceed 
with vXM, organ 
delivered) to 
transplant 
surgery started 
Less than 5hrs Baseline   
5 – 9hrs 2.7 1.1 0.01 
More than 9hrs 7.6 1.7 <0.0001 
Missing 0.8 0.7 0.2 
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Figure legends: 
Figure 1: Logistics of deceased donor transplantation in the United Kingdom 
(DO-Duty office, XM-crossmatch, HD- haemodialysis) 
 
Figure 2: There was significant variation in CIT between centres across the UK, 
expressed as box and whisker plot with mean. The shortest mean CIT was 
12.00hr and the longest of 20.36hr, compared in all 22 centres (F=10.060, 
p<0.0001). 
 
Figure 3: The impact of the cross match type on CIT; transplants that proceeded 
based on a virtual cross match (omitting the prospective pre-transplant donor 
crossmatch test) had a median CIT of approximately 3 hours less than those that 
required a prospective cross match. (t-test, p<0.0001). 
a) Pre-transplant cross match 
b) Virtual cross match 
 
Figure 4: Laboratory variation in practice around use of donor samples for pre-
transplant cross match 
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